Medical Equipment

Atrial Fibrillation Devices Market Developments Driving Growth Across The Forecast Period

April 9, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Value Of The Atrial Fibrillation Devices Market Progress Between 2026 And 2030?

The atrial fibrillation devices market has experienced significant expansion in its size over recent years. Projections show it will expand from $8.6 billion in 2025 to $9.61 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.7%. Historically, this expansion has been driven by factors such as the increasing occurrence of atrial fibrillation, an expanding elderly demographic, a greater burden of cardiovascular diseases, the proliferation of electrophysiology laboratories, and the wider acceptance of implantable cardiac devices.

The atrial fibrillation devices market size is projected to experience swift expansion over the coming years. It is anticipated to reach $14.77 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.3%. This growth during the projected period stems from several factors, including progress in ablation technologies, the wider adoption of remote patient monitoring, heightened public awareness regarding stroke prevention, the increasing number of ambulatory surgical centers, and innovations in mapping and navigation systems. Key trends for the upcoming period encompass the increasing acceptance of catheter ablation procedures, the expanding deployment of wearable and remote ECG monitoring devices, a heightened need for less invasive AFib treatments, the broader application of left atrial appendage closure devices, and a stronger emphasis on early diagnosis and continuous rhythm tracking.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25704&type=smp

Which Drivers Are Supporting The Atrial Fibrillation Devices Market Growth?

The increasing prevalence of cardiovascular conditions is anticipated to drive the expansion of the atrial fibrillation device market in the future. Cardiovascular diseases encompass various ailments impacting the heart and blood vessels, such as heart attacks, strokes, and high blood pressure. The incidence of these diseases is escalating globally, primarily due to rising rates of obesity and diabetes, along with the widespread adoption of inactive lifestyles and unhealthy eating patterns. Atrial fibrillation (AFib) devices are crucial for handling cardiovascular diseases, as they detect, monitor, and treat abnormal heart rhythms, which frequently accompany or result from underlying cardiac issues. For example, in June 2024, figures released by the American Heart Association, a US-based public health body, indicated that with high blood pressure anticipated to climb from 51.2% to 61.0%, the population diagnosed with cardiovascular diseases is forecast to grow from 128 million in 2020 to more than 184 million by 2050. Consequently, the surge in cardiovascular diseases is fueling the development of the atrial fibrillation device market.

Which Segment Categories Are Included In The Atrial Fibrillation Devices Market Segment Analysis?

The atrial fibrillation devices market covered in this report is segmented –

1) By Device Type: Implantable Devices, External Devices, Catheter-Based Devices

2) By Product: Electrophysiology Ablation Catheters, Cardiac Monitors Or Implantable Loop Recorder, Electrophysiology Diagnostic Catheters, Mapping And Recording Systems, Access Devices, Intracardiac Echocardiography, Left Atrial Appendage Closure Devices, Other Products

3) By Technology: Radiofrequency, Cryotherapy, Ultrasound, Other Technologies

4) By Distribution Channel: Direct Sales, Distributors, Online Sales

5) By End-Use: Hospitals, Cardiac Centers, Ambulatory Surgical Centers, Other End Users

Subsegments:

1) By Implantable Devices: Implantable Cardioverter Defibrillators, Pacemakers, Insertable Cardiac Monitors

2) By External Devices: External Defibrillators, Holter Monitors, Mobile Cardiac Telemetry Devices, Electrocardiogram Monitors

3) By Catheter-Based Devices: Radiofrequency Ablation Catheters, Cryoablation Catheters, Laser Ablation Catheters, Mapping and Navigation Systems, Transseptal Access Devices

Which Trends Are Expected To Impact The Atrial Fibrillation Devices Market?

Major companies in the atrial fibrillation devices market are concentrating on technological advancements, such as patient-centric clinical decision support tools, to improve diagnostic accuracy, tailor treatment plans, and enhance overall patient outcomes. These patient-centric clinical decision support tools are digital solutions that assist healthcare professionals in customizing treatment decisions by analyzing individual patient data. For instance, in August 2023, GE HealthCare Technologies Inc., a US-based medical technology company, introduced CardioVisio for Atrial Fibrillation, a digital clinical decision support tool crafted to streamline clinician workflows and support precision care for patients with atrial fibrillation. This tool allows healthcare providers to visualize the progression of AFib, including previous diagnoses, treatments, medications, and associated conditions. The platform also provides guideline-based therapy recommendations, which aids in reducing diagnostic errors and streamlining clinical decision-making. CardioVisio organizes fragmented patient information into an easily accessible format, easing the burden on medical staff and enabling more timely, personalized, and effective management of atrial fibrillation.

Who Are The Active Companies Shaping The Atrial Fibrillation Devices Market?

Major companies operating in the atrial fibrillation devices market are Johnson And Johnson Services Inc, Abbott Laboratories, Medtronic Public Limited Company, Koninklijke Philips NV, Boston Scientific Corporation, Shanghai MicroPort EP MedTech Co Ltd, Japan Lifeline Co Ltd, AliveCor Inc, CardioFocus Inc, Imricor Medical Systems Inc, Kardium Inc, Stereotaxis Inc, Volta Medical, Osypka AG, CathRx Ltd, BIOTRONIK SE And Co KG, EP Solutions SA, CardiacSense Ltd, Biosense Webster Inc, Abbott Electrophysiology, Medtronic Cardiac Rhythm And Heart Failure, Boston Scientific Electrophysiology

Get The Full Atrial Fibrillation Devices Market Report:

https://www.thebusinessresearchcompany.com/report/atrial-fibrillation-devices-global-market-report

Which Region Represents The Largest Share Of The Atrial Fibrillation Devices Market?

North America was the largest region in the atrial fibrillation devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the atrial fibrillation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Atrial Fibrillation Devices Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=25704&type=smp

Browse Through More Reports Similar to the Global Atrial Fibrillation Devices Market 2026, By The Business Research Company

Cardiac Arrhythmia Monitoring Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiac-arrhythmia-monitoring-devices-global-market-report

Ventricular Fibrillation Market Report 2026

https://www.thebusinessresearchcompany.com/report/ventricular-fibrillation-global-market-report

Cardiovascular Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795